Urgent Urinary Incontinence

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

H
HologicMA - Marlborough
1 program
selective bladder denervation using RF energyN/A1 trial
Active Trials
NCT04408352Suspended225Est. May 2030

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Hologicselective bladder denervation using RF energy

Clinical Trials (1)

Total enrollment: 225 patients across 1 trials

NCT04408352Hologicselective bladder denervation using RF energy

RF Ablation of the Trigone for the Treatment of UUI

Start: Apr 2020Est. completion: May 2030225 patients
N/ASuspended

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space